Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease

BACKGROUND: Behçet’s disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) α agents have been used to treat patients with intestinal BD with severe disease activity or those who are resistant to conventional treatments; however, the long-term efficacy of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Haruka, Watanabe, Daisuke, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Takenaka, Haruka, Hoshi, Namiko, Ooi, Makoto, Kodama, Yuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962253/
https://www.ncbi.nlm.nih.gov/pubmed/35346067
http://dx.doi.org/10.1186/s12876-022-02221-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962253/
https://www.ncbi.nlm.nih.gov/pubmed/35346067
http://dx.doi.org/10.1186/s12876-022-02221-0

Ejemplares similares